Advertisement

Topics

Oral Solution for Treatment of Childhood Leukemia Can Now Be Ordered

06:00 EDT 1 Aug 2017 | PharmPro

Xatmep — the first and only ready-to-use methotrexate oral solution is now available. Xatmep is indicated for the treatment of acute lymphoblastic leukemia (ALL) and the management of polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients.
Contributed Author: 
Silvergate Pharmaceuticals, Inc.
Topics: 

Original Article: Oral Solution for Treatment of Childhood Leukemia Can Now Be Ordered

NEXT ARTICLE

More From BioPortfolio on "Oral Solution for Treatment of Childhood Leukemia Can Now Be Ordered"

Quick Search
Advertisement
 

Relevant Topics

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...